AKI biomarkers are poor discriminants for subsequent need for renal replacement therapy, but do not disqualify them yet

Harm-Jan de Grooth¹, Jean-Jacques Parienti^{2

3}, Miet Schetz⁴

Affiliations

¹ Department of Intensive Care, VU University Medical Center, De Boelelaan 1118, 1081 HZ, Amsterdam, The Netherlands.
² Department of Biostatistics and Clinical Research, Centre Hospitalo-Universistaire de Caen, Caen, France.
³ EA2656 Groupe de Recherche sur l'Adaptation Microbienne, Université Caen Normandie, Caen, France.
⁴ Clinical Department and Laboratory of Intensive Care Medicine, Division of Cellular and Molecular Medicine, KU Leuven University, Herestraat 49, 3000, Leuven, Belgium. marie.schetz@uzleuven.be.

Editorial

Harm-Jan de Grooth et al. Intensive Care Med. 2018 Jul.

. 2018 Jul;44(7):1156-1158.

doi: 10.1007/s00134-018-5151-7. Epub 2018 Apr 12.

Harm-Jan de Grooth¹, Jean-Jacques Parienti^{2

3}, Miet Schetz⁴

¹ Department of Intensive Care, VU University Medical Center, De Boelelaan 1118, 1081 HZ, Amsterdam, The Netherlands.
² Department of Biostatistics and Clinical Research, Centre Hospitalo-Universistaire de Caen, Caen, France.
³ EA2656 Groupe de Recherche sur l'Adaptation Microbienne, Université Caen Normandie, Caen, France.
⁴ Clinical Department and Laboratory of Intensive Care Medicine, Division of Cellular and Molecular Medicine, KU Leuven University, Herestraat 49, 3000, Leuven, Belgium. marie.schetz@uzleuven.be.

No abstract available

Comment on

Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis.
Klein SJ, Brandtner AK, Lehner GF, Ulmer H, Bagshaw SM, Wiedermann CJ, Joannidis M. Klein SJ, et al. Intensive Care Med. 2018 Mar;44(3):323-336. doi: 10.1007/s00134-018-5126-8. Epub 2018 Mar 14. Intensive Care Med. 2018. PMID: 29541790 Free PMC article.